A
Alessandro Corso
Researcher at University of Pavia
Publications - 132
Citations - 5733
Alessandro Corso is an academic researcher from University of Pavia. The author has contributed to research in topics: Multiple myeloma & Bortezomib. The author has an hindex of 28, co-authored 129 publications receiving 4757 citations.
Papers
More filters
Journal ArticleDOI
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Meletios A. Dimopoulos,Andrew Spencer,M. Attal,H. Miles Prince,Jean Luc Harousseau,Anna Dmoszynska,Jesús F. San Miguel,Andrzej Hellmann,Thierry Facon,Robin Foà,Alessandro Corso,Zvenyslava Masliak,Marta Olesnyckyj,Zhinuan Yu,John Patin,Jerome B. Zeldis,Robert Knight +16 more
TL;DR: Lenalidomide plus dexamethasone is more effective than high-dose dexamETHasone alone in relapsed or refractory multiple myeloma.
Journal ArticleDOI
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Antonio Palumbo,Roman Hájek,Michel Delforge,Martin Kropff,Maria Teresa Petrucci,John Catalano,Heinz Gisslinger,Wieslaw Wiktor-Jedrzejczak,Mamia Zodelava,Katya C Weisel,Nicola Cascavilla,Genadi Iosava,Michele Cavo,Janusz Kloczko,Joan Bladé,Meral Beksac,Ivan Spicka,Torben Plesner,Joergen Radke,Christian Langer,Dina Ben Yehuda,Alessandro Corso,Lindsay Herbein,Zhinuan Yu,Jay Mei,Christian Jacques,Meletios A. Dimopoulos +26 more
TL;DR: MPR-R significantly prolonged progression-free survival in patients with newly diagnosed multiple myeloma who were ineligible for transplantation, with the greatest benefit observed in patients 65 to 75 years of age.
Journal ArticleDOI
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Francesco Passamonti,Chiara Cattaneo,Luca Arcaini,Riccardo Bruna,Michele Cavo,Francesco Merli,Emanuele Angelucci,Mauro Krampera,Roberto Cairoli,Matteo G. Della Porta,Nicola Stefano Fracchiolla,Marco Ladetto,Carlo Gambacorti Passerini,Marco Salvini,Monia Marchetti,Roberto M. Lemoli,Alfredo Molteni,Alessandro Busca,Antonio Cuneo,Alessandra Romano,Nicola Giuliani,Sara Galimberti,Alessandro Corso,Alessandro Morotti,Brunangelo Falini,Atto Billio,Filippo Gherlinzoni,Giuseppe Visani,Maria Chiara Tisi,Agostino Tafuri,Patrizia Tosi,Francesco Lanza,Massimo Massaia,Mauro Turrini,Felicetto Ferrara,Carmela Gurrieri,Daniele Vallisa,Maurizio Martelli,Enrico Derenzini,Attilio Guarini,Annarita Conconi,Annarosa Cuccaro,Laura Cudillo,Domenico Russo,Fabrizio Ciambelli,Anna Maria Scattolin,Mario Luppi,Carmine Selleri,Elettra Ortu La Barbera,Celestino Ferrandina,Nicola Di Renzo,Attilio Olivieri,Monica Bocchia,Massimo Gentile,Francesco Marchesi,Pellegrino Musto,Augusto B. Federici,Anna Candoni,Adriano Venditti,Carmen Fava,Antonio Pinto,Piero Galieni,Luigi Rigacci,Daniele Armiento,Fabrizio Pane,Margherita Oberti,Patrizia Zappasodi,Carlo Visco,Matteo Franchi,Paolo Grossi,Lorenza Bertù,Giovanni Corrao,Livio Pagano,Paolo Corradini +73 more
TL;DR: This study adds to the evidence that patients with haematological malignancies have worse outcomes and the general Italian population with COVID-19 has high mortality, by calculating standardised mortality ratios between observed death in the study cohort and expected death by applying stratum-specific mortality rates.
Journal ArticleDOI
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
Marzia Varettoni,Alessandro Corso,Gianmatteo Pica,Silvia Mangiacavalli,Cristiana Pascutto,M. Lazzarino +5 more
TL;DR: The incidence of EM disease has increased, probably due to the availability of more sensitive imaging techniques and the prolongation of patients' survival, and HDT or novel agents seem not to increase the risk ofEM disease.
Journal ArticleDOI
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni,Luca Arcaini,Silvia Zibellini,Emanuela Boveri,Sara Rattotti,Roberta Riboni,Alessandro Corso,Ester Orlandi,Maurizio Bonfichi,Manuel Gotti,Cristiana Pascutto,Silvia Mangiacavalli,Giorgio Alberto Croci,Valeria Fiaccadori,Lucia Morello,Maria Luisa Guerrera,Marco Paulli,Mario Cazzola +17 more
TL;DR: Findings indicate that the allele-specific PCR developed is a useful diagnostic tool for patients with Waldenström's macroglobulinemia or IgM-MGUS, and may therefore also represent a useful prognostic marker.